Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Abbott in $575 million deal for endometriosis drug
Abbott in $575 million deal for endometriosis drug
Abbott in $575 million deal for endometriosis drug
Submitted by
admin
on June 16, 2010 - 8:24am
Source:
Marketwatch
News Tags:
Abbott Laboratories
endometriosis
Elagolix
Neurocrine
Headline:
Abbott in $575 million deal for endometriosis drug
Do Not Allow Advertisers to Use My Personal information